Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

global access

Search Listening as a Tool to Inform Brand Strategy & Enable Patient-Centricity

Julia Walsh, CEO of Brand Medicine International, explores the concept of “search listening” in healthcare, and how it can be used to inform brand strategy, improve patient-centricity, and fight scientific...

Impetus Digital

Webcast

Amplifying the patient voice: How to conduct patient research sensitively to uncover emotional insights

Inizio

Top 10 Tips for Running a Successful Virtual Event

Based on 13 years of experience in virtualizing life science meetings and events

Impetus Digital

- PMLiVE

UK plans to launch new national health agency focused on tackling pandemics

The UK Health Security Agency will protect against future health threats

- PMLiVE

EU, UK working towards a ‘win-win’ situation to expand COVID-19 vaccine supplies

EU leaders are set to meet today to discuss proposed vaccine export plans

- PMLiVE

AZ publishes primary analysis for COVID-19 vaccine, showing slightly lower efficacy of 76%

AZ previously announced vaccine efficacy of 79% in US-based trial

- PMLiVE

Responsibly growing our talent pool

Talent remains the healthcare communications sector’s most important asset and its biggest challenge

Case studies

[CASE STUDIES] Delivering remote access to congress, symposia and enduring materials

See how three pharma companies supported the provision of virtual and on-demand scientific meetings for HCPs during COVID-19.

EPG Health

Integrated NHS finances: what do they mean for High Cost Drugs?

Oli Hudson and Steve How, of Wilmington Healthcare, explore NHS England’s new system-level funding and its impact on prescribing for High Cost Drugs

Wilmington Healthcare

- PMLiVE

New data for Recordati’s Isturisa reinforces benefit in Cushing’s disease

Drug provided 'rapid and sustained' normalisation of mean urinary-free cortisol levels

- PMLiVE

Keytruda plus chemotherapy gains US approval for advanced oesophageal cancer

First checkpoint inhibitor to win approval in the first-line setting for this cancer type

- PMLiVE

Pfizer launches early study of COVID-19 antiviral therapeutic

Therapeutic candidate has demonstrated 'potent' in vivo activity against SARS-CoV-2

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links